Yupingfeng Granules for asthma remission
Yupingfeng Granules may be used as an adjunct for a nonpregnant adult in clinical asthma remission with a lung-Qi deficiency pattern including spontaneous sweating, aversion to wind, shortness of breath, fatigue, susceptibility to colds, and possibly sneezing, nasal obstruction, and clear discharge. This description refers only to Yupingfeng Granules with a locked authorization number, manufacturer, strength, and current product information. The listed ingredients are generally Huangqi, Baizhu, and Fangfeng, but the locked product's current information is the sole boundary and no modifications are allowed. A 2023 integrated Chinese-Western medicine guideline gives grade C evidence and a strong recommendation but explicitly notes a lack of direct studies in clinical asthma remission and reliance mainly on adjacent-population evidence and expert decisions; this stage-extrapolation limitation must remain.
This treatment is for a nonpregnant adult in clinical asthma remission with spontaneous sweating, aversion to wind, shortness of breath, fatigue, susceptibility to colds, and possibly sneezing, nasal obstruction, and clear discharge consistent with lung-Qi deficiency. It uses only Yupingfeng Granules whose authorization number, manufacturer, strength, and current product information have been confirmed. The listed composition must not be changed, and different manufacturers or strengths must not automatically be treated as equivalent. The physician determines actual use according to current product information and individual risk; patients must not self-medicate using a fixed dose. It cannot replace inhaled-corticosteroid-containing controller treatment, inhaler-technique review, a written action plan, or acute-exacerbation care. The 2023 guideline gives grade C evidence and a strong recommendation but explicitly lacks direct studies in clinical asthma remission and relies mainly on adjacent-population evidence and expert decisions; this stage-extrapolation limitation must remain. Allergy, autoimmune disease, immunosuppressive treatment, pregnancy or breastfeeding, and polypharmacy require individual review. It must not be used as a general cold-prevention medicine.
Quick Reference
Treatment
20 mins – 45 mins
Observation
0.2 months – 0.5 months
Department
Traditional Chinese Medicine Internal Medicine
Who Is This For
Is Yupingfeng Granules for asthma remission Right for You?
Good Candidates
- Adult asthma confirmed by variable symptoms and objective variable airflow evidence, without a current acute exacerbation
- A nonpregnant adult in clinical remission with spontaneous sweating, aversion to wind, shortness of breath, fatigue, susceptibility to colds, and possibly sneezing, nasal obstruction, and clear discharge indicating lung-Qi deficiency
- Willingness to reassess predefined symptom and functional measures at 7 to 14 days rather than continuing indefinitely without supervision
- Understanding that this plan cannot replace inhaled-corticosteroid-containing controller treatment, inhaler-technique review, a written action plan, or acute-exacerbation care
May Not Be Suitable
- Current worsening wheeze or breathlessness, restricted speech, hypoxemia, a substantial fall in peak flow, or poor response to reliever medicine
- Pregnancy or breastfeeding, childhood, hepatic or renal dysfunction, or polypharmacy without specific assessment
- Allergy to a preparation ingredient or excipient, a previous severe adverse drug reaction, or inability to obtain a compliant product with a verifiable authorization number and current product information
Step-by-Step Process
How Yupingfeng Granules for asthma remission Works
Confirm the disease and exit conditions
Review asthma diagnostic information, current control, exacerbations in the past year, and all inhaled medicines and exclude current worsening wheeze or breathlessness, restricted speech, hypoxemia, a substantial peak-flow fall, or poor reliever response.
Differentiate the pattern and review the evidence boundary
Confirm a nonpregnant adult is in clinical remission with spontaneous sweating, aversion to wind, shortness of breath, fatigue, susceptibility to colds, and possibly sneezing, obstruction, and clear discharge indicating lung-Qi deficiency. Explain the 2023 guideline's grade C, strong recommendation and its lack of direct remission-stage studies and reliance on adjacent populations and expert decisions.
Lock the preparation and complete pharmacist review
Lock the authorization number, manufacturer, strength, and current product information for Yupingfeng Granules. The physician and pharmacist review indications, excipients, sugar content, contraindications, and interactions. Do not alter composition, copy across strengths, or automatically interchange manufacturers.
Short-cycle reassessment
Reassess predefined symptoms, function, and adverse effects at 7 to 14 days. If there is no clear benefit or the condition changes, stop renewal and return to causal and standard-care pathways.
Set a 7-day observation window according to the locked product's current information and the physician's prescription. At review, check adherence, adverse effects, and standard treatment. Do not renew or change manufacturer or strength without review.
Cost Information
Cost Estimate for Yupingfeng Granules for asthma remission
What's Included
Actual costs should be understood as uninsured full self-pay for a person not resident in China in a standard outpatient clinic. Suitability and the specific manufacturer, dosage form, strength, amount, and course must be determined by the physician from the diagnosis. Final prices may differ by product and hospital; rely on the actual prescription and the treating hospital's charges.
Before Your Visit
What to Prepare
Required Tests & Examinations
If you already have recent valid test results, bring the reports. If not, these assessments can usually be completed in China before the procedure.
Asthma diagnostic information, current control, exacerbations in the past year, and every inhaled medicine
Review of every current prescription and nonprescription medicine, herbal medicine, and supplement
CBC and hepatic and renal function selected according to disease, age, and medicine risk
Documents & Materials to Bring
Required to Bring
Disease diagnosis, stage, and recent test information
A complete list of medicines, allergies, and adverse reactions
A 1- to 2-week symptom or function record
A compliant preparation with verifiable authorization number, manufacturer, strength, and current product information
Companion & Support
Most adults do not need a companion. Family help to review medicines is advisable for first use, older age, multiple conditions, or international care.
After Treatment
Recovery & Follow-Up
Record changes in symptoms and function and avoid starting several new treatments whose effects cannot be distinguished.
Short-term improvement must not interrupt inhaled-corticosteroid-containing controller treatment, inhaler-technique review, a written action plan, or acute-exacerbation care.
Promptly report a new rash, difficulty breathing, jaundice, marked weakness, palpitations, or urine-volume change.
Do not buy loose herbs, open and reformulate granules, increase the amount, interchange manufacturers, or extend the course on your own.
Follow-Up Schedule
Formally review at 7 to 14 days. Stop and seek immediate care for disease warning signs, allergy, persistent gastrointestinal reactions, jaundice, urine-volume change, palpitations, or neurologic symptoms.
Related Conditions
Conditions This Procedure Treats
Ready to Plan Yupingfeng Granules for asthma remission in China?
Let Carevia help you find the right hospital, coordinate your treatment, and arrange every detail of your medical trip.
Frequently Asked Questions
Need personalized guidance?
Our care coordinators can help you assess whether this procedure fits your situation.
Contact Us